Abstract:

BACKGROUND: The catgut embedding technology can embed the line body of biodegradable materials to the specific body parts or points through minimally invasive devices, and it can adjust the meridians and organs function for disease treatment through biodegradable line body formed long-term stimulus in the meridian points.
OBJECTIVE: To compare the clinical effect of poly-lactic-co-glycolic acid new catgut embedding material and catgut and to investigate the application characteristics of poly-lactic-co-glycolic acid new catgut embedding material.
METHODS: 150 patients treated with embedding was selected and divided into observation group and control group, 75 patients in each group. In the observation group, there were 32 patients with spinal diseases, 22 patients with epilepsy and 21 patients with nervous tinnitus, and all the patients were treated with poly-lactic-co-glycolic acid new catgut embedding material; in the control group, there were 20 patients with spinal diseases, 23 patients with epilepsy and 23 patients with nervous tinnitus, and all the patients were treated with catgut. The effect and the infrared thermography of the two materials were compared and statistically analyzed to observe whether there was significant difference of the efficacy and local reactions between two catgut embedding materials.
RESULTS AND CONCLUSION: The effective rate for the spinal disease patients was 87.50% in observation group, 81.82% for epilepsy patients and 90.48% for nervous tinnitus patients; in the control group, the effective rate for the spinal disease patients was 79.31%, 69.57% for epilepsy patients and 78.26% for nervous tinnitus patients; there was no significant difference of the effective rate for different diseases between two embedding materials. For the partialbody temperature, the time to return to normal in the observation group was shorter than that in the control group, and there was significant difference between two groups (P < 0.05). For the effect on the acupoint catgut embedding treatment, there were no significant advantages of poly-lactic-co-glycolic acid new catgut embedding material when compared with catgut, but the poly-lactic-co-glycolic acid new catgut embedding material has the advantages of not easy to allergy, lower partial rejection and lower infection risk, which can help to improve the overall treatment efficacy, so the poly-lactic-co-glycolic acid new catgut embedding material is worthy for the clinical application.